Literature DB >> 21127980

Autoimmune hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).

Palak Jitendrakumar Trivedi, Sue Cullen.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21127980     DOI： 10.1007/s10620-010-1476-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  18 in total

1.  Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.

Authors:  Robert J Wong; Robert Gish; Todd Frederick; Natalie Bzowej; Catherine Frenette
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

2.  Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

Authors:  Jordan J Feld; Huong Dinh; Tamara Arenovich; Victoria A Marcus; Ian R Wanless; E Jenny Heathcote
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

3.  Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

Authors:  Franco Trevisani; Stefania De Notariis; Gianludovico Rapaccini; Fabio Farinati; Luisa Benvegnù; Marco Zoli; Gian Luca Grazi; Poggio Paolo Del; NolfoMariaAnna Di; Mauro Bernardi
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

4.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

5.  A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus.

Authors:  Elena Santagostino; Massimo Colombo; Monica Rivi; Maria Grazia Rumi; Angiola Rocino; Silvia Linari; Pier Mannuccio Mannucci
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

6.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

7.  Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan.

Authors:  Masatoshi Makuuchi; Norihiro Kokudo; Shigeki Arii; Shunji Futagawa; Shuichi Kaneko; Seiji Kawasaki; Yutaka Matsuyama; Masatoshi Okazaki; Kiwamu Okita; Masao Omata; Yukihisa Saida; Tadatoshi Takayama; Yoshio Yamaoka
Journal:  Hepatol Res       Date:  2008-01       Impact factor: 4.288

8.  Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.

Authors:  O S Lin; E B Keeffe; G D Sanders; D K Owens
Journal:  Aliment Pharmacol Ther       Date:  2004-06-01       Impact factor: 8.171

9.  Hepatocellular carcinoma in patients with autoimmune hepatitis.

Authors:  Andreas Teufel; Arndt Weinmann; Catherine Centner; Anja Piendl; Ansgar W Lohse; Peter R Galle; Stephan Kanzler
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

Review 10.  Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis.

Authors:  M Anzola
Journal:  J Viral Hepat       Date:  2004-09       Impact factor: 3.728
View more
  8 in total

1.  Wls Expression Correlates with Tumor Differentiation and TNM Stage in Hepatocellular Carcinoma.

Authors:  Chao Zhou; Yuejun Sun; Shuwei Guo; Xiao Chen; Genchong Bao; Jiandong Wang
Journal:  Dig Dis Sci       Date:  2017-11-10       Impact factor: 3.199

2.  Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan.

Authors:  Hiromasa Ohira; Kazumichi Abe; Atsushi Takahashi; Mikio Zeniya; Takafumi Ichida
Journal:  J Gastroenterol       Date:  2012-06-13       Impact factor: 7.527

3.  Intent-to-treat analysis of liver transplant for hepatocellular carcinoma in the MELD era: impact of hepatitis C and advanced status.

Authors:  Zhenhua Hu; Zhiwei Li; Jie Xiang; Jie Zhou; Sheng Yan; Jian Wu; Lin Zhou; Shusen Zheng
Journal:  Dig Dis Sci       Date:  2014-07-10       Impact factor: 3.199

4.  Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.

Authors:  Tania M Welzel; Barry I Graubard; Sabah Quraishi; Stefan Zeuzem; Jessica A Davila; Hashem B El-Serag; Katherine A McGlynn
Journal:  Am J Gastroenterol       Date:  2013-06-11       Impact factor: 10.864

Review 5.  Hepatocellular carcinoma in patients with autoimmune hepatitis - a systematic review of the literature published between 1989-2016.

Authors:  Simona Valean; Monica Acalovschi; Dan L Dumitrascu; Lidia Ciobanu; Georgiana Nagy; Romeo Chira
Journal:  Med Pharm Rep       Date:  2019-04-25

6.  Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice.

Authors:  Kerstin Herzer; Anna Carbow; Svenja Sydor; Jan-Peter Sowa; Stefan Biesterfeld; Thomas-Georg Hofmann; Peter-Robert Galle; Guido Gerken; Ali Canbay
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

7.  Circulating histones are major mediators of systemic inflammation and cellular injury in patients with acute liver failure.

Authors:  Zongmei Wen; Zhen Lei; Lu Yao; Ping Jiang; Tao Gu; Feng Ren; Yan Liu; Chunyan Gou; Xiuhui Li; Tao Wen
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

8.  Analysis of Differentially Expressed Proteins Involved in Autoimmune Cirrhosis and Normal Serum by iTRAQ Proteomics.

Authors:  Zheng Minghui; Hu Kunhua; Bao Yunwen; Lu Hongmei; Li Jing; Wu Shaowen; Sun Longqiaozi; Duan Chaohui
Journal:  Proteomics Clin Appl       Date:  2018-08-09       Impact factor: 3.494
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.